Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC
Clinical trial NCT03665441 · COMPLETED
Trial details
- NCT number
- NCT03665441
- Sponsor
- ERYtech Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-15
- Primary completion
- 2021-08-30
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.